Similar articles

• [Zoladex in prostatic carcinoma].

  Di Silverio F, Serio M. Di Silverio F, et al. Drugs Exp Clin Res. 1990;16 Suppl:19-29. Drugs Exp Clin Res. 1990. PMID: 2150501 Clinical Trial. Italian. No abstract available.
• [Treatment of carcinoma of the prostate with analogs of LHRH].

  Rubio Herrera MA, Calle Fernández JR. Rubio Herrera MA, et al. Rev Clin Esp. 1986 Nov;179(8):407-11. Rev Clin Esp. 1986. PMID: 2951782 Spanish. No abstract available.
• [Treatment of cancer of the prostate. Role of gonadorelin analogs].

  Steg A. Steg A. Presse Med. 1989 May 20;18(20):1007-9. Presse Med. 1989. PMID: 2524792 French. No abstract available.
• [Luteinizing hormone-releasing hormone agonists for treatment of breast cancer].

  Gez E, Kovner F. Gez E, et al. Harefuah. 1990 Jun 1;118(11):655-8. Harefuah. 1990. PMID: 2143745 Review. Hebrew. No abstract available.
• Luteinizing hormone-releasing hormone (LHRH) agonists for treatment of advanced prostatic carcinoma.

  Chodak GW. Chodak GW. Urology. 1989 May;33(5 Suppl):42-4. doi: 10.1016/0090-4295(89)90105-2. Urology. 1989. PMID: 2523610 Review.